What is the ticker symbol for CohBar?

CohBar trades under the ticker CWBR on NASDAQ.

What sector does CohBar operate in?

CohBar is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CWBR in a portfolio?

PortView shows CWBR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

CohBar (CWBR) Stock Analysis

NASDAQHealthcareBiotechnology

$0.41+0.00%

1-year price historyRange $0.00 – $1.01

52-week range$0.41

$0.00$1.01

What CohBar does

CohBar Inc. is a clinical-stage biotechnology company dedicated to the discovery and advancement of therapies that leverage mitochondrial biology, known as mitochondria-based therapeutics (MBTs). Their primary objective is to combat chronic conditions and diseases associated with aging. These MBTs are being developed to address a broad spectrum of medical challenges, including non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis (IPF), type 2 diabetes, acute respiratory distress syndrome (ARDS), various cancers, and cardiovascular disorders like Alzheimer's disease. Their flagship clinical asset is CB4211, an innovative, optimized analogue of the MOTS-c mitochondrial-derived peptide. This candidate is currently undergoing Phase Ib evaluation as part of a larger Phase Ia/Ib clinical trial, specifically targeting non-alcoholic steatohepatitis (NASH) and obesity. Beyond their clinical work, CohBar's preclinical portfolio features CB5138 analogs aimed at fibrotic conditions, as well as CB5064 analogs being explored for their potential in treating ARDS linked to COVID-19. Established in 2007, CohBar, Inc. maintains its corporate headquarters in Menlo Park, California.

Key metrics

Market cap

$1.19M

P/E (TTM)

-0.09

EPS (TTM)

$-4.37

Beta

1.38

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$0.48

200-day avg

$0.54

52-week high

$1.01

52-week low

$0.00

CEO

Pinchas Cohen Dean,

ETFs linked to CWBR

Broad-market and Healthcare sector ETFs an investor holding CohBar is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CWBR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CWBR in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for CohBar?: CohBar trades under the ticker CWBR on NASDAQ.
Which exchange is CWBR listed on?: CWBR is listed on NASDAQ.
What sector does CohBar operate in?: CohBar is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CWBR in a portfolio?: PortView shows CWBR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.